Background illustration for clinical trials search

Chronic Lymphocytic Leukemia Clinical Trials

Browse 1,522 chronic lymphocytic leukemia clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Study of AUBE00 in Patients With Solid Tumors

for
Solid Tumors
Location: Fairfax VA, Grand Rapids MI, Houston TX
Sponsor: Chugai Pharmaceutical

Sex: All

Age: 18+

Code: NCT07030959

Phase 1, Recruiting

A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties

for
Blood Cancer, Lymphoma, Leukemia, Myeloma
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07052916

Recruiting

A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials

for
Cancer
Location: Jacksonville FL
Sponsor: University of Florida

Sex: All

Age: 18 - 70+

Code: NCT05655494

Recruiting

Study of ISM3412 in Participants With Locally Advanced/Metastatic Solid Tumors

for
Locally Advanced/Metastatic Solid Tumors
Location: New Haven CT, Indianapolis IN, Nashville TN, Denver CO,
Sponsor: InSilico Medicine Hong Kong Limited

Sex: All

Age: 18+

Code: NCT06414460

Phase 1, Phase 2, Recruiting

Imaging of Solid Tumors Using 18F-TRX

for
Solid Tumor, Solid Carcinoma,
Location: San Francisco CA
Sponsor: Rahul Aggarwal

Sex: All

Age: 18+

Code: NCT06942104

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Phase 1 Study of BAFF CAR-T Cells (LMY-920) for Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma

for
Relapsed CLL, Refractory CLL, Refractory Lymphoma
Location: Cleveland OH
Sponsor: Paolo Caimi, MD

Sex: All

Age: 18+

Code: NCT06916767

Phase 1, Recruiting

Barriers to Vegetarian Diets

for
Chronic Disease
Location: Baltimore MD
Sponsor: University of Maryland, Baltimore

Sex: All

Age: 18 - 70+

Code: NCT07075653

Recruiting

Solution-Focused Brief Therapy for Support of Psychological Distress in Adolescent and Young Adult Cancer Survivors

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Ann Arbor MI
Sponsor: University of Michigan Rogel Cancer Center

Sex: All

Age: 15 - 39

Code: NCT06941324

Recruiting

A Study of ZL-1310 in Participants With Selected Solid Tumors

for
Solid Tumors
Location: New York NY, Philadelphia PA, Norfolk VA, Fairfax VA,
Sponsor: Zai Lab (Shanghai) Co., Ltd.

Sex: All

Age: 18+

Code: NCT06885281

Phase 1, Phase 2, Recruiting

Community Enhanced Virtual Informed Consent

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Jacksonville FL
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT07805083

Recruiting

A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors

for
Advanced Solid Tumor, Metastatic Solid Tumor
Location: Philadelphia PA, Celebration FL, Sioux Falls SD,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06803680

Phase 1, Recruiting

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

for
Pancreatic Ductal Adenocarcinoma, Non Small Cell Lung Cancer,
Location: Boston MA, New York NY, Philadelphia PA, Baltimore MD,
Sponsor: Verastem, Inc.

Sex: All

Age: 18+

Code: NCT07020221

Phase 1, Phase 2, Recruiting

A Study of Live Tumor Fragments of Surgical Resections

for
Cancer, Tumor
Location: Jacksonville FL
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT07000864

Recruiting

Immune Reconstitution in Stem Cell Transplant Recipients

for
Cancer
Location: Miami FL
Sponsor: University of Miami

Sex: All

Age: 18 - 70+

Code: NCT02129543

Recruiting

A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers

for
Oncology, Myeloid Leukemia, Acute, Cancer
Location: Rochester NY, Chapel Hill NC, Winston-Salem NC,
Sponsor: University of Rochester

Sex: All

Age: 60+

Code: NCT06697600

Recruiting

Study to Evaluate the Pharmacokinetics and Safety of Pralatrexate in Patients With Advanced Solid Tumor or Hematological Malignancy and Either Normal Hepatic Function or Mild, Moderate, or Severe Hepatic Impairment

for
Advanced Solid Tumors, Hematologic Malignancies
Location: Canton OH, Detroit MI, Chicago IL
Sponsor: Acrotech Biopharma Inc.

Sex: All

Age: 18+

Code: NCT07036133

Phase 1, Recruiting

Investigating Memory and Physical Activity After Cancer Treatment in Survivors of Adolescent and Young Adult Cancers

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Scottsdale AZ
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06880861

Recruiting

New Assessment System in Measuring Symptom Distress in Cancer Patients

for
Caregiver, Health Care Provider, Malignant Neoplasm, Physician
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT00505245

Recruiting

Outreach Project to Connect Underrepresented Populations to Clinical Trials at Ohio State University, CUSP2CT Project Trial

for
Hematopoietic and Lymphoid System Neoplasm,
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center

Sex: All

Age: 0+

Code: NCT06314672

Recruiting

A Natural History Study of Metabolic Sizing in Health and Disease

for
Metabolic Disorders, Cancer, Chronic Kidney Disease, Diabetes,
Location: Bethesda MD
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Sex: All

Age: 2 - 70+

Code: NCT05398783

Recruiting

What is chronic lymphocytic leukemia?

Chronic lymphocytic leukemia, or CLL, is a slow growing cancer of B lymphocytes that build up in the blood, bone marrow, and lymph nodes. Most people are diagnosed around age 70, often with no symptoms; when symptoms come, they include tiredness, swollen lymph nodes, frequent infections, night sweats, and weight loss. Small lymphocytic lymphoma is the same disease when the cells sit mainly in lymph nodes, so it is studied in the same trials.

When treatment is needed, it is now mostly targeted pills: BTK inhibitors taken continuously, or venetoclax based combinations taken for a fixed time. CAR T cell therapy was approved for CLL in 2024 for people whose disease has stopped responding to both. Genetic features such as TP53 mutation, deletion 17p, and IGHV status strongly predict how CLL behaves and which trials fit. Other leukemias are on our leukemia clinical trials page.

Types of CLL clinical trials

Who can participate in CLL clinical trials?

How CLL is staged, and why it matters for trials

How to enroll in a CLL clinical trial